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Abstract
Objective : To determine the effect of oral Misoprostol after 
Radical Hysterectomy in the early stage Cervical Cancer to 
reduce the incidence of urinary retention.
Methods : The study was conducted with a prospective 
cohort method, randomized control trial and double-blind to 
the patients with early-stage cervical cancer who performed 
Radical Hysterectomy in Dr. Zainoel Abidin hospital, Banda 
Aceh. There are 34  subjects who agreed to participate in the 
study. Subjects were divided into 2 groups. The fi rst group 
who received Misoprostol orally as the intervention group 
and the other group that received placebo as the control 
group.
Results : The incidence of urinary retention after Radical 
Hysterectomy in Dr. Zainoel Abidin hospital, Banda 
Aceh, decreased signifi cantly in the intervention group 
compared to the control group (P 0,049). In the intervention 
group Misoprostol reduce residual urine. Ability to void 
spontaneously and urine volume were increase. The duration 
of catheterization and length of hospital stay for the patients 
were  shorter.
Conclusions : Administration of Misoprostol orally reduce 
the incidence of urinary retention after Radical Hysterectomy. 
Oral Misoprostol can be recommended as an additional 
procedure to reduce urinary retention.
Keywords : cervical cancer, misoprostol , radical 
hysterectomy, urinary retention.
Abstrak
Tujuan : Untuk mengetahui pengaruh pemberian 
Misoprostol per oral pascaoperasi Histerektomi Radikal 
pada pasien karsinoma Serviks stadium awal terhadap 
insidensi retensio urin.
Metode : Penelitian dilakukan dengan metode kohort 
prospektif, randomized control trial dan double blind, pada 
pasien karsinoma serviks stadium awal yang dilakukan 
Histerektomi Radikal di RS dr. Zainoel Abidin, Banda Aceh. 
Terdapat 34 pasien yang telah menyetujui mengikuti 
penelitian, yang dibagi dalam 2 kelompok yaitu kelompok 
yang mendapat Misoprostol tablet per oral sebagai kelompok 
perlakuan dan kelompok yang mendapat plasebo sebagai 
kelompok kontrol. Residu urin pada kedua kelompok diukur 
dan faktor-faktor lain yang terkait dilakukan pendataan 
untuk dilakukan analisis.
Hasil : Kejadian retensio urin pascahisterektomi Radikal di RS 
dr. Zainoel Abidin, Banda Aceh, menurun secara  bermakna 
pada kelompok perlakuan dibandingkan kelompok kontrol 
(P0,049). Pada kelompok perlakuan Misoprostol menurunkan 
residu urin. Peningkatan kemampuan berkemih spontan dan 
volume urin .lama pemakaian kateter transuretra dan lama 
perawatan menjadi lebih singkat.
Kesimpulan : Pemberian Misoprostol per oral  mengurangi 
insiden retensio urin pascahisterektomi Radikal.
Saran : Misoprostol per oral dapat direkomendasikan sebagai 
prosedur tambahan untuk mengurangi retensio urin.
Kata kunci : karsinoma serviks, histerektomi radikal, 
misoprostol, retensio urin.
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INTRODUCTION
Cervical cancer ranks second in Indonesia due to 
the number of cancer patients in women but as a 
cause of death was the fi rst rank. Based on WHO 
data (World Health Organization) in 2008 it is 
estimated that every day there are 38 new cases 
of Cervical Carcinoma and 21 women who died 
of Cervical Cancer in Indonesia.1 Based on 2013 
Riset Kesehatan Dasar (Riskesdas) conducted by 
the Ministry of Health Litbangkes, prevalence 
of sufferers cervical cancer in Aceh Province is 
equivalent to prevalence of Indonesian national 
cervical cancer, which is 1.4 / 1,000 population 
or two people per 1,000 population.2 Based on 
secondary data from Zainoel Abidin General 
Hospital Banda Aceh in 2013, the majority of cases 
of Cervical Cancer (61%) wherein the early stages 
(stadium 1A, stadium 1B and stadium IIA).3
Urinary retention is the most frequent 
complication of surgery Radical Hysterectomy 
of the Early-stage Cervical Cancer and causes 
voiding dysfunction with an incidence of 8% - 
80%. Twenty of percent of patients who have had 
a Radical Hysterectomy developed Vesika Urinary 
dysfunction up to 3 months postoperatively.4-6
Misoprostol is a drug that is often used for the 
treatment of urinary retention. The effects of these 
drugs can increase Detrusor muscle contractions. 
Misoprostol is a PGE1 derivative. Pharmaco kinetic 
Oral administration of Misoprostol is more rapidly 
absorbed than intravaginal administration.7-9 The 
authors want to prevent the occurrence of Urinary 
Retention by administering Misoprostol orally 
as a prophylaxis to reduce bladder dysfunction 
morbidity. Therefore the authors are interested 
in assessing the effectiveness of Misoprostol per 
oral administration to reduce the incidence of 
urinary retention after Radical Hysterectomy.
METHODS
This research design is a Randomized Control 
Trial, Double blind study. The group was given 
oral Misoprostol tablets with a catheter after 
Radical Hysterectomy was called the intervention 
group and the group was given a placebo with 
a catheter as the control group. The study was 
conducted after the ethical clearance approved by 
ethical committee, at the Division of Gynecology 
Oncology, Zainoel Abidin general Hospital Banda 
Aceh and started from January 2017 to October 
2018. The target population in this study were 
all patients who have had Radical Hysterectomy 
in the early stage Cervical Cancer (stage 1A, 1B, 
2A).
Inclusion criteria were: patients after radical 
hysterectomy in the early stage cervical cancer 
and agreed to take part in the study by signing 
an informed consent. Exclusion criteria were 
patients with a history of urinary retention before 
surgery, urinalysis and LEA tests showing urinary 
tract infections, hydronephrosis, chronic urinary 
retention and urinary incontinence, Urethral 
stricture and history of Vesika Urinary injury. The 
number of subjects in this study were 34 patients 
consisting of 17 intervention groups and 17 
control groups. The randomization method used 
SNOSE (sequentially, numbered, opaque, sealed, 
sealed envelope) or using sequential, numbered 
envelopes, envelopes that are not transparent 
and closed.
Patients were given oral misoprostol tablets 
200 μg per 12 hours, within 24 hours after radical 
hysterectomy. All patients have a transurethral 
catheter placed after surgery hysterectomy for 
emptying the bladder for 1 x 24 hours. After 
the catheter is removed the patient is observed, 
as follows: Within 6 hours of observation, the 
patient is given a drink water 100 cc per hour. If 
the patient wants and able to void spontaneously, 
perform measurement for residual urine using a 
catheter. If residual urine is less than 100 ml, then 
the patient is considered capable of spontaneous 
voiding. If residual urine is 100-500 ml or more, 
the patient has urinary retention and continue 
to urinary retention management. If within 
6 hours observation the patient is unable to 
void spontaneously, the patient's urine will be 
removed by transurethral catheter for 24 hours. 
Observation of the research will be carried out 
until the patient can spontaneously urinate again 
with urine residue less than 100 ml and suitable 
for discharged from the hospital. Data collection 
of factors related to urinary retention after 
radical hysterectomy were: bladder capacity, 
spontaneous voiding time, urine volume, length 
of stay, intraoperative blood loss, time of surgery 
for radical hysterectomy and side effects of 
Misoprostol. Data will be analyzed using the SPSS 
22 software with signifi cance P-value <0.05.
RESULT
During the study period, we included 34 research 
subject who met our inclusion and exclusion 
criteria. General characteristics of study subject 
are shown in table 1.
statistical calculation showed that the independent 
sample test results with P-value 0.049, which 
means there are signifi cant differences. Based on 
the data that the administration of misoprostol 
after radical hysterectomy can reduce the residual 
urine.
Correlation between Administration of 
Misoprostol Tablets and Volume of Residual 
Urine 100 ml or more (Urinary Retention)
In 34 patient who has had radical hysterectomy, 
there were 16 research subject with residual 
urine 100 ml or more after transurethral catheter 
removal. Thirteen (38.2%) cases were from 
the control group and 3 cases (8.8%) from the 
intervention group. In the statistical calculation 
using the Chi-square test, the difference between 
the occurrence of urine residual volume of ≥ 
100 ml between these groups is signifi cant 
with P-value 0.002. These fi ndings show that 
administration of misoprostol tablets after radical 
hysterectomy can reduce residual urine volume 
to less than 100 ml.
Correlation between Administration 
Misoprostol Tablets and placebo to  Residual 
Volume after Catheter Removal
In 34 patient, 6 research subject were found 
in the control group who were unable to void 
spontaneously after catheter removal, only 11 
research subject residual urine could be measured. 
All intervention groups were able to void after 
catheter removal, resulting in 17 research subject 
of residual urine that could be measured. The 
Correlation between Administration of 
Misoprostol Tablets with Spontaneous 
Voiding ability
There were 6 research subject unable to void 
spontaneously (17.6%) all of which occurred in the 
control group. All patients (17 research subject 
(50.1%)) in the intervention group were able to 
void spontaneously, whereas in the control group 
there were 11 research subject were able to void 
spontaneously (32.3%). Statistical calculations 
Table 1. General Characteristic of Research Subject Table 2. Correlation between the Administration of 
Misoprostol Tablets with Mean Urine  Residual Volume
Table 3. Correlation between the Administration of 
Misoprostol Tablets and Volume of Residul Urine ≥ 100 ml 
(urinary retention)
Variable Frequency (n)
Group
Group
Intervention
Control
P=0.049
Control
Intervention
Total Cases
P= 0.002
13 Cases (38.2%)
3 Cases (8.8 %)
16
4 Cases (11.7 %)
14 Cases (41.3 %)
18
17
11
52.6 ml
159.5 ml
47.9
155.6
Total Case SDMean urine residual volume
Urine residual volume
≥ 100 ml
Urine residual volume
< 100 ml
(%)
Intervention group (Misoprostol) 
Control group  (Placebo)
Urinary retention
Control
Intervention
Without urinary retention
Control
Intervention
Age 
40-45 
46-50 
51-55 
56-60 
61-65 
65-70 
underweight
Normal 
Overweight 
Obesity
Parity
Parity 1
Parity 2-4
Parity>4
Cervical Cancer Staging
Stage 1A
Stage 1B
Stage 2A
Able to void spontaneously
Control
Intervention
Unable to void spontaneously
Control
Intervention
Intraoperative bleeding ≥500 cc
Urinary retention
Without urinary retention
Intraoperative bleeding <500 cc
Urinary retention
Without urinary retention
17
17
13
3
4
14
4
4
12
11
2
1
0
27
5
2
0
15
19
1
15
18
11
17
6
0
12
7
4
11
50
50
38.2
8.8
11.7 
41.3
11.7
11.7
35.3
32.3
5.8 
3.2 
0 
79.4
14.7
5.9
0
44.1 
55.9
2.9 
44.1 
53 
32.3
50.1
17.6
0
35.3 
20.5 
11.7
32.5
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using the Chi-square test, the difference between 
the administration of misoprostol tablets and 
the ability to void spontaneously after catheter 
removal between these groups were signifi cant 
with  P-value 0.018.
Correlation between Administration 
Misoprostol Tablets and Bladder Capacity
In the control group there were 11 research 
subject were able to void spontaneously with 
mean bladder capacity 327,2 ml. All patient 
in the intervention group were able to void 
spontaneously with mean bladder capacity 360,5 
ml. In the statistical calculation of this study using 
the independent sample test, the P-value 0.479. 
It means that there is no signifi cant difference 
in bladder capacity between the intervention 
group and the control group. It can be concluded 
that administration Misoprostol after radical 
hysterectomy has no effect on bladder capacity.
Correlation between Administration 
Misoprostol Tablets and the First Time of 
Voiding Postradical Hysterectomy
Based on the data of the fi rst voiding response 
after radical hysterectomy, it shows the fi rst 
time of voiding after radical hysterectomy in the 
intervention group more faster than the control 
group (117.6 vs 237.2 minutes). In the statistical 
calculation using the independent sample 
test obtained P 0.001, which means there are 
signifi cant differences.
Correlation between the Administration of 
Misoprostol Tablets with Length of Hospital 
Stay
Based on statistical calculations using the 
independent sample test, the difference in length 
of hospital stay between the intervention and 
control groups was signifi cant with a P-value 
of 0.001. The mean length of hospital stay in 
the intervention group was 3.3 days, while the 
average length of the control group was 4.8 days. 
The data showed that the length of hospital stay 
in the intervention group was more shorten than 
the control group.
Correlation between Retention of Urine and 
Amount of Intraoperative Bleeding
In this study, an amount of intraoperative bleeding 
depends on the stage of cervical cancer and the 
extent of the operating area. Urinary retention 
with the amount of intraoperative bleeding> 
500cc was found in 12 (35%) research subject 
and 7 (20.5%) research subject without urinary 
retention. In the case of radical hysterectomy 
with intraoperative bleeding ≤ 500, 4 (11.7%) 
research subjects have had urinary retention 
and 11 without urinary retention (32.3%). The 
results of statistical analysis using the Chi-square 
test obtained P-value 0.07 this data showed no 
signifi cant differences.
Side Effect
The administration of misoprostol orally 200 
micrograms every 12 hours did not have serious 
side effects, and no patients dropped out from this 
study. Three of the 17 patients were administered 
misoprostol, complained of cramping in the 
abdominal wall with mild intensity and transient 
abdominal pain. These side effects do not require 
treatment and always self-limiting. Other side 
effects such as diarrhoea, chest pain, hypotension, 
arrhythmia and shivering were not found in both 
groups.
DISCUSSION
Residual urine is affected by Detrusor muscle 
contractions. The physiology of voiding and 
bladder emptying process play a role in decreasing 
residual urine. Misoprostol, a PGE1 analogue 
causes open calcium channels so that extracellular 
calcium will easily enter the intracellular and bind 
to calmodulin which will activate the formation 
of MLC Kinase which facilitates the formation of 
P-Myosin. The myosin crossbridge to bind the 
actin fi lament to allow contraction of the detrusor 
muscle. Oral administration of misoprostol after 
radical hysterectomy can reduce residual urine 
volume. This condition is caused by the ability 
of prostaglandin to improve tone recovery and 
detrusor bladder muscle activity so that the 
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bladder's ability to empty all of the urine more 
better. Normal voiding requires an adequate 
Detrusor tone and low resistance to the bladder 
neck and urethra.10,11 This study shows that 
misoprostol can increase the contraction of 
detrusor muscle.
Administration of misoprostol tablets after radical 
hysterectomy can reduce residual urine volume to 
less than 100 ml and increase spontaneous voiding 
ability.12,13This also corresponds with research 
that prostaglandin can accelerate recovery and 
activate detrusor bladder muscle tone. Existing 
literature found signifi cant differences after 
vaginal hysterectomy procedure which given a 
prostaglandin 1.5 mg analogue intravaginally. 
Regarding to the study the mean residual urine 
signifi cantly decrease.14,15
Pathophysiology mechanism of lower urinary 
tract function changes after radical hysterectomy. 
The urinary bladder wall undergoes decline in the 
elastic muscular properties  caused by surgical 
injury and partial damage from the autonomic 
bladder innervation.16-18 Literature revealed that 
the rate of postoperative voiding dysfunction 
depends on the resection of vaginal, paravaginal 
and parametrial tissue.19,20 In Literature, 47% of 
women in the early stage cervical cancer post 
radical hysterectomy undergo urinary retention 
with residual urine  ≥ 100 ml. In general, the initial 
transient changes after radical hysterectomy 
consist of reduced bladder capacity, detrusor 
hypoactivity, and reduced bladder sensation.
Literature has shown that decline in bladder 
compliance occurs after radical hysterectomy.21,22 
The data shows the fi rst time of voiding after 
radical hysterectomy in the intervention group 
more faster than the control group (117.6 minutes 
vs 237.2 minutes, P <0.001). The administration of 
misoprostol can shorten the fi rst time of voiding 
after radical hysterectomy, improve compliance 
and increase the proprioceptive sensation and 
bladder sensation.
In this study showed a signifi cant increase 
in urine volume in the intervention group after 
radical hysterectomy (312.6 ml vs. 201.3 ml). 
Based on statistical calculations, there are 
signifi cant differences so that oral administration 
of misoprostol after radical hysterectomy can 
increase urine volume.
Administration of misoprostol tablets after 
radical hysterectomy can reduce the length of stay 
and reduce residual urine. This data corresponds 
that length of stay postoperative ranging from 1 
to 6 days. Bergman's research stated that giving 
Misoprostol will shorten the length of stay.23
An amount of intraoperative bleeding after 
radical hysterectomy showed that there was no 
signifi cant difference in cases of bleeding more 
than 500 cc or less than 500 cc due to occurrence 
of urinary retention, so it can be concluded that the 
incidence of urinary retention was not related to 
an amount of intraoperative radical hysterectomy. 
Urinary retention was associated with an amount 
of intraoperative bleeding correspond to the 
research which stated that urinary retention was 
not caused by intraoperative bleeding, but was 
probably due to an expansion of the operating 
area which could cause innervation of Pelvicus 
nerve in the lower urinary tract.24,25
CONCLUSION
Oral administration of misoprostol tablets can 
reduce the incidence of urinary retention after 
radical hysterectomy. Oral administration of 
misoprostol tablets can reduce residual urine 
volume, increase spontaneous voiding ability, 
increase urine volume, shortening the fi rst time 
of voiding after radical hysterectomy and reduce 
length of hospital stay. There was no signifi cant 
correlation with oral misoprostol tablets with 
decreased bladder capacity. An amount of 
intraoperative bleeding has no signifi cant 
correlation with the incidence of urinary 
retention.
RECOMMENDATION
The author recommend that a larger sample 
group can yield more accurate study result. 
Expanding research variables and conducting 
pre-operative examinations to measure detrusor 
muscle strength and urethral resistance.
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